{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T04:16:58Z","timestamp":1747455418398},"reference-count":24,"publisher":"Japanese Society of Internal Medicine","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,3,1]]},"DOI":"10.2169\/internalmedicine.2969-23","type":"journal-article","created":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T22:11:02Z","timestamp":1704147062000},"page":"665-669","source":"Crossref","is-referenced-by-count":2,"title":["Relapse of Ulcerative Colitis with Immune Thrombocytopenia and Pyoderma Gangrenosum Subsequent to Receiving COVID-19 Vaccination"],"prefix":"10.2169","volume":"63","author":[{"given":"Kohei","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Coloproctology & Gastroenterology, Fukushima Medical University Aizu Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Aizawa","sequence":"additional","affiliation":[{"name":"Department of Coloproctology & Gastroenterology, Fukushima Medical University Aizu Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kana","family":"Tamazawa","sequence":"additional","affiliation":[{"name":"Department of Coloproctology & Gastroenterology, Fukushima Medical University Aizu Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Coloproctology & Gastroenterology, Fukushima Medical University Aizu Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Coloproctology & Gastroenterology, Fukushima Medical University Aizu Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Coloproctology & Gastroenterology, Fukushima Medical University Aizu Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goro","family":"Shibukawa","sequence":"additional","affiliation":[{"name":"Department of Coloproctology & Gastroenterology, Fukushima Medical University Aizu Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fukushima Medical University Aizu Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saburo","family":"Tsunoda","sequence":"additional","affiliation":[{"name":"Department of Hematology, Fukushima Medical University Aizu Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazutomo","family":"Togashi","sequence":"additional","affiliation":[{"name":"Department of Coloproctology & Gastroenterology, Fukushima Medical University Aizu Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Rodr\u00edguez Y, Rojasb M, Beltr\u00e1nb S, et al. Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review. J Autoimmun 132: 102898, 2022.","DOI":"10.1016\/j.jaut.2022.102898"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Masuta Y, Watanabe T, Minaga K, Kudo M. A case of ulcerative colitis relapse characterized by systemic type I interferon responses after COVID-19 vaccination. Inflamm Bowel Dis 28: e110-e111, 2022.","DOI":"10.1093\/ibd\/izac031"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Sahin U, Muik A, Derhovanessian E, et al. COVID-19 vaccine BNT162b1 elicits human antibody and T<sub>H<\/sub>1 T cell responses. Nature 586: 594-599, 2020.","DOI":"10.1038\/s41586-020-2814-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Miyashita Y, Yoshida T, Takagi Y, et al. Circulating extracellular vesicle microRNAs associated with adverse reactions, proinflammatory cytokine, and antibody production after COVID-19 vaccination. NPJ Vaccines 7: 16, 2022.","DOI":"10.1038\/s41541-022-00439-3"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Ndeupen S, Qin Z, Jacobsen S, Bouteau A, Estanbouli H, Igy\u00e1rt\u00f3 BZ. The mRNA-LNP platform&apos;s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory. iScience 24: 103479, 2021.","DOI":"10.1016\/j.isci.2021.103479"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hiraoka S, Fujiwara A, Toyokawa T, et al. Multicenter survey on mesalamine intolerance in patients with ulcerative colitis. Gastroenterology 36: 137-143, 2021.","DOI":"10.1111\/jgh.15138"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Nakase H, Sato N, Mizuno N, Ikawa Y. The influence of cytokines on the complex pathology of ulcerative colitis. Autoimmun Rev 21: 103017, 2022.","DOI":"10.1016\/j.autrev.2021.103017"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. James D, Jena A, Bharath PN, et al. Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: a systematic review and meta-analysis. Dig Liver Dis 54: 713-721, 2022.","DOI":"10.1016\/j.dld.2022.03.005"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Yamamoto T. Epidemiology of pyoderma gangrenosum in Japanese patients by questionnaire survey. J Dermatol 46: e145-e146, 2019.","DOI":"10.1111\/1346-8138.14658"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Farhi D, Cosnes J, Zizi N, et al. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Medicine (Baltimore) 87: 281-293, 2008.","DOI":"10.1097\/MD.0b013e318187cc9c"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Marzano AV, Cugno M, Trevisan V, et al. Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol 162: 100-107, 2010.","DOI":"10.1111\/j.1365-2249.2010.04201.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Marzano AV, Damiani G, Ceccherini I, Berti E, Gattorno M, Cugno M. Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis). Br J Dermatol 176: 1588-1598, 2017.","DOI":"10.1111\/bjd.15226"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Maronese CA, Pimentel MA, Li MM, Genovese G, Ortega-Loayza AG, Marzano AV. Pyoderma gangrenosum: an updated literature review on established and emerging pharmacological treatments. Am J Clin Dermatol 23: 615-634, 2022.","DOI":"10.1007\/s40257-022-00699-8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Agarwal A, Andrews JM. Systematic review: IBD-associated pyoderma gangrenosum in the biologic era, the response to therapy. Aliment Pharmacol Ther 38: 563-572, 2013.","DOI":"10.1111\/apt.12431"},{"key":"15","unstructured":"15. Motamed F, Zandieh F, Sedighi M. Crohn&apos;s disease and idiopathic thrombocytopenic purpura in a patient with ectodermal dysplasia and immunodeficiency. Iran J Allergy Asthma Immunol 5: 143-145, 2006."},{"key":"16","unstructured":"16. Queliza K, Ihekweazu FD, Ali A, Kellermayer R. Inflammatory bowel disease and immune thrombocytopenic purpura: combined immune dysregulation in an adolescent. Ann Clin Lab Sci 47: 226-228, 2017."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Chandra S, Finn S, Obah E. Immune thrombocytopenic purpura in ulcerative colitis: a case report and systematic review. J Community Hosp Intern Med Perspect 4: 23386, 2014.","DOI":"10.3402\/jchimp.v4.23386"},{"key":"18","unstructured":"18. Zlatanic J, Korelitz BI, Wischet N, et al. Inflammatory bowel disease and immune thrombocytopenic purpura: is there a correlation? Am J Gastroenterol 92: 2285-2288, 1997."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lee EJ, Marina BM, Hanny AS, et al. SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP. Blood 139: 1564-1574, 2022.","DOI":"10.1182\/blood.2021013411"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Moulis G, Crickx E, Thomas L, et al.; the French Covigilance COVID-19 Vaccine-ITP Study Group. De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring. Blood 139: 2561-2565, 2022.","DOI":"10.1182\/blood.2022015470"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Choi PY, Hsu D, Tran HA, et al. Immune thrombocytopenia following vaccination during the COVID-19 pandemic. Haematologica 107: 1193-1196, 2022.","DOI":"10.3324\/haematol.2021.279442"},{"key":"22","unstructured":"22. David P, Dotan A, Mahroum N, Shoenfeld Y. Immune thrombocytopenic purpura triggered by COVID-19 infection and vaccination. Isr Med Assoc J 23: 378-380, 2021."},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Grimaldi-Bensouda L, Michel M, Aubrun E, et al.; the PGRx Immune Thrombocytopenia Study Group. A case-control study to assess the risk of immune thrombocytopenia associated with vaccines. Blood 120: 4938-4944, 2012.","DOI":"10.1182\/blood-2012-05-431098"},{"key":"24","unstructured":"24. Mir-Madjlessi SH, Taylor JS, Farmer RG. Clinical course and evolution of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis: a study of 42 patients. Am J Gastroenterol 80: 615-620, 1985."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/5\/63_2969-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T03:38:35Z","timestamp":1709350715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/5\/63_2969-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2969-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,1]]},"article-number":"2969-23"}}